mirror of
https://github.com/msberends/AMR.git
synced 2025-07-08 12:31:58 +02:00
website update
This commit is contained in:
@ -242,18 +242,18 @@
|
||||
<p>The data set looks like this now:</p>
|
||||
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb3-1" title="1"><span class="kw"><a href="https://www.rdocumentation.org/packages/utils/topics/head">head</a></span>(my_TB_data)</a>
|
||||
<a class="sourceLine" id="cb3-2" title="2"><span class="co"># rifampicin isoniazid gatifloxacin ethambutol pyrazinamide moxifloxacin</span></a>
|
||||
<a class="sourceLine" id="cb3-3" title="3"><span class="co"># 1 R R S I S S</span></a>
|
||||
<a class="sourceLine" id="cb3-4" title="4"><span class="co"># 2 S R I R S R</span></a>
|
||||
<a class="sourceLine" id="cb3-5" title="5"><span class="co"># 3 S S S S R R</span></a>
|
||||
<a class="sourceLine" id="cb3-6" title="6"><span class="co"># 4 R S R S S S</span></a>
|
||||
<a class="sourceLine" id="cb3-7" title="7"><span class="co"># 5 I R R S R R</span></a>
|
||||
<a class="sourceLine" id="cb3-8" title="8"><span class="co"># 6 S S S S S S</span></a>
|
||||
<a class="sourceLine" id="cb3-3" title="3"><span class="co"># 1 S S R S R S</span></a>
|
||||
<a class="sourceLine" id="cb3-4" title="4"><span class="co"># 2 R R S S R S</span></a>
|
||||
<a class="sourceLine" id="cb3-5" title="5"><span class="co"># 3 R S R R S S</span></a>
|
||||
<a class="sourceLine" id="cb3-6" title="6"><span class="co"># 4 S I R S R R</span></a>
|
||||
<a class="sourceLine" id="cb3-7" title="7"><span class="co"># 5 R S R R S S</span></a>
|
||||
<a class="sourceLine" id="cb3-8" title="8"><span class="co"># 6 I I S S R S</span></a>
|
||||
<a class="sourceLine" id="cb3-9" title="9"><span class="co"># kanamycin</span></a>
|
||||
<a class="sourceLine" id="cb3-10" title="10"><span class="co"># 1 S</span></a>
|
||||
<a class="sourceLine" id="cb3-11" title="11"><span class="co"># 2 R</span></a>
|
||||
<a class="sourceLine" id="cb3-12" title="12"><span class="co"># 3 S</span></a>
|
||||
<a class="sourceLine" id="cb3-13" title="13"><span class="co"># 4 R</span></a>
|
||||
<a class="sourceLine" id="cb3-14" title="14"><span class="co"># 5 R</span></a>
|
||||
<a class="sourceLine" id="cb3-14" title="14"><span class="co"># 5 S</span></a>
|
||||
<a class="sourceLine" id="cb3-15" title="15"><span class="co"># 6 R</span></a></code></pre></div>
|
||||
<p>We can now add the interpretation of MDR-TB to our data set:</p>
|
||||
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1">my_TB_data<span class="op">$</span>mdr <-<span class="st"> </span><span class="kw"><a href="../reference/mdro.html">mdr_tb</a></span>(my_TB_data)</a>
|
||||
@ -263,15 +263,14 @@
|
||||
<a class="sourceLine" id="cb4-5" title="5"><span class="co"># Version: WHO/HTM/TB/2014.11</span></a>
|
||||
<a class="sourceLine" id="cb4-6" title="6"><span class="co"># Author: WHO (World Health Organization)</span></a>
|
||||
<a class="sourceLine" id="cb4-7" title="7"><span class="co"># Source: https://www.who.int/tb/publications/pmdt_companionhandbook/en/</span></a>
|
||||
<a class="sourceLine" id="cb4-8" title="8"><span class="co"># Warning: Reliability might be improved if these antimicrobial results</span></a>
|
||||
<a class="sourceLine" id="cb4-9" title="9"><span class="co"># would be available too: `CAP` (capreomycin), `RIB` (rifabutin), `RFP`</span></a>
|
||||
<a class="sourceLine" id="cb4-10" title="10"><span class="co"># (rifapentine)</span></a></code></pre></div>
|
||||
<a class="sourceLine" id="cb4-8" title="8"><span class="co"># Warning: Reliability might be improved if these antimicrobial results would</span></a>
|
||||
<a class="sourceLine" id="cb4-9" title="9"><span class="co"># be available too: CAP (capreomycin), RIB (rifabutin), RFP (rifapentine)</span></a></code></pre></div>
|
||||
<p>And review the result with a frequency table:</p>
|
||||
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw"><a href="../reference/freq.html">freq</a></span>(my_TB_data<span class="op">$</span>mdr)</a></code></pre></div>
|
||||
<p><strong>Frequency table of <code>mdr</code> from <code>my_TB_data</code> (5,000 x 8)</strong></p>
|
||||
<p>Class: <code>factor</code> > <code>ordered</code> (<code>numeric</code>)<br>
|
||||
<p>Class: factor > ordered (numeric)<br>
|
||||
Length: 5,000 (of which NA: 0 = 0.00%)<br>
|
||||
Levels: 5: <code>Negative</code> < <code>Mono-resistance</code> < <code>Poly-resistance</code> < <code>Multidrug res...</code><br>
|
||||
Levels: 5: Negative < Mono-resistance < Poly-resistance < Multidrug resistance…<br>
|
||||
Unique: 5</p>
|
||||
<table class="table">
|
||||
<thead><tr class="header">
|
||||
@ -286,40 +285,40 @@ Unique: 5</p>
|
||||
<tr class="odd">
|
||||
<td align="left">1</td>
|
||||
<td align="left">Mono-resistance</td>
|
||||
<td align="right">3,288</td>
|
||||
<td align="right">65.8%</td>
|
||||
<td align="right">3,288</td>
|
||||
<td align="right">65.8%</td>
|
||||
<td align="right">3,240</td>
|
||||
<td align="right">64.8%</td>
|
||||
<td align="right">3,240</td>
|
||||
<td align="right">64.8%</td>
|
||||
</tr>
|
||||
<tr class="even">
|
||||
<td align="left">2</td>
|
||||
<td align="left">Negative</td>
|
||||
<td align="right">686</td>
|
||||
<td align="right">13.7%</td>
|
||||
<td align="right">3,974</td>
|
||||
<td align="right">79.5%</td>
|
||||
<td align="right">641</td>
|
||||
<td align="right">12.8%</td>
|
||||
<td align="right">3,881</td>
|
||||
<td align="right">77.6%</td>
|
||||
</tr>
|
||||
<tr class="odd">
|
||||
<td align="left">3</td>
|
||||
<td align="left">Multidrug resistance</td>
|
||||
<td align="right">560</td>
|
||||
<td align="right">11.2%</td>
|
||||
<td align="right">4,534</td>
|
||||
<td align="right">90.7%</td>
|
||||
<td align="right">638</td>
|
||||
<td align="right">12.8%</td>
|
||||
<td align="right">4,519</td>
|
||||
<td align="right">90.4%</td>
|
||||
</tr>
|
||||
<tr class="even">
|
||||
<td align="left">4</td>
|
||||
<td align="left">Poly-resistance</td>
|
||||
<td align="right">269</td>
|
||||
<td align="right">5.4%</td>
|
||||
<td align="right">4,803</td>
|
||||
<td align="right">96.1%</td>
|
||||
<td align="right">279</td>
|
||||
<td align="right">5.6%</td>
|
||||
<td align="right">4,798</td>
|
||||
<td align="right">96.0%</td>
|
||||
</tr>
|
||||
<tr class="odd">
|
||||
<td align="left">5</td>
|
||||
<td align="left">Extensive drug resistance</td>
|
||||
<td align="right">197</td>
|
||||
<td align="right">3.9%</td>
|
||||
<td align="right">202</td>
|
||||
<td align="right">4.0%</td>
|
||||
<td align="right">5,000</td>
|
||||
<td align="right">100.0%</td>
|
||||
</tr>
|
||||
|
Reference in New Issue
Block a user